One swab, two tests: Validation of dual SARS-CoV-2 testing on the Abbott ID NOW™

BACKGROUND: Point-of-care tests (POCT) are promising tools to detect SARS-CoV-2 in specific settings. Initial reports suggest the ID NOW™ COVID-19 assay (Abbott Diagnostics Inc, USA) is less sensitive than standard real-time reverse transcription polymerase chain reaction (rRT-PCR) assays. This has...

Descripción completa

Detalles Bibliográficos
Autores principales: Burnes, Laura E, Clark, Shawn T, Sheldrake, Elena, Faheem, Amna, Poon, Betty P, Christie-Holmes, Natasha, Finlay, Laura, Kandel, Christopher, Phan, Michael, Frankland, Caylin, Lau, Trevor, Gubbay, Jonathan B, Corbeil, Antoine, Katz, Kevin, Kozak, Robert A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196482/
https://www.ncbi.nlm.nih.gov/pubmed/34174710
http://dx.doi.org/10.1016/j.jcv.2021.104896

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196482/
https://www.ncbi.nlm.nih.gov/pubmed/34174710
http://dx.doi.org/10.1016/j.jcv.2021.104896

Ejemplares similares